Practice Guidelines in Oncology - Gastric Cancer

®
Practice Guidelines
NCCN in Oncology – v.1.2007
21. Chau I, Norman AR, Cunningham D, et al. Multivariate
prognostic factor analysis in locally advanced and metastatic
esophago-gastric cancer--pooled analysis from three multicenter,
randomized, controlled trials using individual patient data. J Clin
Oncol 2004;22:2395-2403.
22. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total
gastrectomy for gastric cancer: five-year survival rates in a
multicenter randomized Italian trial. Italian Gastrointestinal Tumor
Study Group. Ann Surg 1999;230:170-178.
23. MacDonald JS, Smalley SR, Benedetti J, et al.
Chemoradiotherapy after surgery compared with surgery alone for
adenocarcinoma of the stomach or gastroesophageal junction. N
Engl J Med 2001;345:725-730.
24. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode
dissection for gastric cancer. Dutch Gastric Cancer Group. N
Engl J Med 1999;340:908-914.
25. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph
node dissection for gastric cancer: who may benefit? Final results of
the randomized Dutch gastric cancer group trial. J Clin Oncol
2004;22:2069-2077.
26. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after
D1 and D2 resections for gastric cancer: long-term results of the
MRC randomized surgical trial. Surgical Co-operative Group. Br J
Cancer 1999;79:1522-1530.
27. McCulloch P, Nita ME, Kazi H, et al. Extended versus limited
lymph nodes dissection technique for adenocarcinoma of the
stomach. Cochrane Database Syst Rev 2004;(4):CD001964.
Gastric Cancer
Manuscript
update in
progress
Version 1.2007, 03/09/07 © 2007 National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN.
Guidelines Index
Gastric Table of Contents
Staging, MS, References
28. Mansfield PF. Lymphadenectomy for gastric cancer. J Clin Oncol
2004;22:2759-2761.
29. Degiuli M, Sasako M, Ponti A, et al. Survival results of a
multicentre phase II study to evaluate D2 gastrectomy for gastric
cancer. Br J Cancer 2004;90:1727-1732.
30. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery:
morbidity and mortality results from a prospective randomized
controlled trial comparing D2 and extended para-aortic
lymphadenectomy--Japan Clinical Oncology Group study 9501. J
Clin Oncol 2004;22:2767-2773.
31. Jansen EP, Boot H, Verheij M, et al. Optimal locoregional
treatment in gastric cancer. J Clin Oncol 2005;23:4509-4517.
32. van de Velde CJ, Peeters KC. The gastric cancer treatment
controversy. J Clin Oncol 2003;21:2234-2236.
33. Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of
survival in node-negative gastric cancer. Ann Surg 2003;237:828-835.
34. Hyung WJ, Cheong JH, Kim J, et al. Application of minimally invasive
treatment for early gastric cancer. J Surg Oncol 2004;85:181-185.
35. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection
for treatment of early gastric cancer. Gut 2001;48:225-229.
36. Matsumoto Y, Yanai H, Tokiyama H, et al. Endoscopic
ultrasonography for diagnosis of submucosal invasion in early
gastric cancer. J Gastroenterol 2000;35:326-331.
37. Yanai H, Noguchi T, Mizumachi S, et al. A blind comparison of
the effectiveness of endoscopic ultrasonography and endoscopy in
staging early gastric cancer. Gut 1999;44:361-365.
REF-2